A luciferase lysis assay reveals in vivo malignant cell sensitization by phosphoantigen prodrugs.
Sign Up to like & getrecommendations! Published in 2019 at "Biochemical pharmacology"
DOI: 10.1016/j.bcp.2019.113668
Abstract: Human Vγ9Vδ2 T cells respond to small phosphorus-containing compounds, often called phosphoantigens, which are now known to be intracellular ligands of the immune receptor butyrophilin 3A1 (BTN3A1). In order to compare the efficiency of butyrophilin… read more here.
Keywords: lysis assay; luciferase lysis; phosphoantigen prodrugs; lysis ... See more keywords